3rd Quarter - Report
SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.) for SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.)
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions related to the IPAB
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Copyright/Patent/Trademark CPT
General patent reform initiatives (no specific bill #)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Medicare/Medicaid MMM
Issues regarding Medicare Part D, Medicare reimbursement issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Budget/Appropriations BUD
Discussions related to deficit reduction (no specific legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.